The FedEx Institute of Technology has declared its partnership with pharmacy services company good shepherd Pharmacy to develop new blockchain-based infrastructure to assist cancer patients get medications, news outlet commercial appeal reported July 6.
The FedEx Institute of Technology is an organization that serves as a promoter of interdisciplinary analysis in rising technologies that operates in tandem with the research infrastructure of the University of Memphis. The organization launched the Institute in February of this year so as to create University of Memphis a center of technology and research.
Memphis-based Good shepherd Pharmacy's reportedly recognized blockchain as a method to retrieve unused medications from cancer patients and pass them on to economically disadvantaged patients who wouldn't be able to often afford them. A secure and immutable ledger would allow for a secure and confidential distribution of medical data. Good shepherd Pharmacy's corporate executive Phil Baker said:
“In Tennessee alone, over $10 million worth of perfectly good prescription medication gets flushed down the toilet every year. Blockchain is the solution for that problem. The REMEDI project (REclaiming MEDicine) will divert valuable medication into the hands of patients who would not otherwise use it."
The Institute can host an occasion to draw in blockchain experts and enthusiasts to discuss Good Shepherd’s proposed initiative. The event will be held in tandem with Blockchain 901, a professional organization that aims to expand the tech work force in the Memphis space.
In May, FedEx ceo Fred Smith said that blockchain is “the next frontier that’s going to fully change worldwide supply chains.” In february, FedEx joined the Blockchain in Transport Alliance (BiTA), a focus group whose members include rail operator BNSF, JD logistics, and GE Transportation.
Last month, another blockchain-based pharmaceutical project was proclaimed by Microsoft and provide tracking solutions provider Adents. The new system offers end-to-end traceability and visibility from the point of origin along the whole supply chain, which allows users to trace single product things within a case.
The FedEx Institute of Technology is an organization that serves as a promoter of interdisciplinary analysis in rising technologies that operates in tandem with the research infrastructure of the University of Memphis. The organization launched the Institute in February of this year so as to create University of Memphis a center of technology and research.
Memphis-based Good shepherd Pharmacy's reportedly recognized blockchain as a method to retrieve unused medications from cancer patients and pass them on to economically disadvantaged patients who wouldn't be able to often afford them. A secure and immutable ledger would allow for a secure and confidential distribution of medical data. Good shepherd Pharmacy's corporate executive Phil Baker said:
“In Tennessee alone, over $10 million worth of perfectly good prescription medication gets flushed down the toilet every year. Blockchain is the solution for that problem. The REMEDI project (REclaiming MEDicine) will divert valuable medication into the hands of patients who would not otherwise use it."
The Institute can host an occasion to draw in blockchain experts and enthusiasts to discuss Good Shepherd’s proposed initiative. The event will be held in tandem with Blockchain 901, a professional organization that aims to expand the tech work force in the Memphis space.
In May, FedEx ceo Fred Smith said that blockchain is “the next frontier that’s going to fully change worldwide supply chains.” In february, FedEx joined the Blockchain in Transport Alliance (BiTA), a focus group whose members include rail operator BNSF, JD logistics, and GE Transportation.
Last month, another blockchain-based pharmaceutical project was proclaimed by Microsoft and provide tracking solutions provider Adents. The new system offers end-to-end traceability and visibility from the point of origin along the whole supply chain, which allows users to trace single product things within a case.
">
0 comments:
Post a Comment